5. EVALUATION THE EFFECTIVENESS OF THE CERVICAL LYMPHADENOPATHY ULTRASOUND-GUIDED CORE NEEDLE BIOPSY
Main Article Content
Abstract
Objective: To evaluate the effectiveness of The Ultrasound-Guided Core Needle Biopsy (US-CNB) technique in a group of patients with suspected cervical lymph nodes on clinic and ultrasound.
Subjects and Methods: This cross-sectional descriptive study on 201 patients with suspected cervical lymph nodes underwent US-CNB at the Department of Diagnostic Ultrasound of the 108 Military Central Hospital from January 2022 to September 2023.
Results: The patient’s mean age was 55.4 years old, with a high proportion of men (71.1%); 88.1% of patients were diagnosed from the first US-CNB and did not need open biopsy and 11.9% of patients need a second US-CNB or open biopsy for pathology. The sensitivity, specificity and accuracy of cervical lymph node biopsy under ultrasound were 93.4%, 100% and 95.5%, respectively. The proportions of the groups of metastatic lymph nodes, lymphoma, and benign lymph nodes were 52.2%, 15.9% and 31.9%, respectively. In the lymphoma group, the accuracy of technique was 65.6%. 4 patients (2%) had mild bleeding in the lymph nodes and along the biopsy needle. There were no severe complications such as death, severe bleeding, infection, or nerve damage.
Conclusion: Ultrasound-guided biopsy in cervical lymph node is a safe and effective method of diagnosing abnormal lymph nodes in the neck, with high accuracy and minimal invasiveness.
Article Details
Keywords
Biopsy, Ultrasound, cervical lymph node.
References
and aspiration biopsy cytology. Review of 376
superficial nodes. Cancer;54(6), 1984, 1076-1081.
[2] Steel BL, Schwartz MR, Ramzy I, Fine
needle aspiration biopsy in the diagnosis of
lymphadenopathy in 1,103 patients. Role,
limitations and analysis of diagnostic pitfalls.
Acta cytologica; 39(1), 1995, 76-81.
[3] Nasuti J, Yu G, Boudousquie A et al., Diagnostic
value of lymph node fine needle aspiration
cytology: an institutional experience of 387 cases
observed over a 5‐year period. Cytopathology;
11(1), 2000, 18-31.
[4] Oh K, Woo J-S, Cho J-G et al., Efficacy of
ultrasound-guided core needle gun biopsy in
diagnosing cervical lymphadenopathy. European
Annals of Otorhinolaryngology, Head and Neck
Diseases;133(6), 2016, 401-404.
[5] Han F, Xu M, Xie T et al., Efficacy of
ultrasound-guided core needle biopsy in cervical
lymphadenopathy: A retrospective study of 6,695
cases. European Radiology. 2018;28:1809-1817.
[6] Vassallo P, Wernecke K, Roos N, Peters PE.
Differentiation of benign from malignant
superficial lymphadenopathy: the role of
high-resolution US. Radiology;183(1), 1992,
215-220.
[7] Huang PC, Liu CY, Chuang WY et al.,
Ultrasound-guided core needle biopsy of cervical
lymphadenopathy in patients with lymphoma:
the clinical efficacy and factors associated with38
unsuccessful diagnosis. Ultrasound in medicine
& biology;36(9), 2010, 1431-1436.
[8] Screaton NJ, Berman LH, Grant JW, Head and
neck lymphadenopathy: evaluation with USguided
cutting-needle biopsy. Radiology;224(1),2002, 75-81.
[9] Schleder S, Jung E-M, Schicho A et al.,
Efficacy and safety of ultrasound-guided
core needle biopsies (US-CNBs) in cervical
lymphadenopathy in patients with suspected head
and neck cancer during the COVID-19 pandemic.
Clinical Hemorheology and Microcirculation,
2023;(Preprint):1-12.
[10] Jennings P, Coral A, Donald J et al., Ultrasound
guided core biopsy. The Lancet;333(8651),
1989, 1369-1371.
[11] Demharter J, Müller P, Wagner T et
al., Percutaneous core-needle biopsy of
enlarged lymph nodes in the diagnosis and
subclassification of malignant lymphomas.
European radiology;11, 2001, 276-283.
[12] de Larrinoa AF, del Cura J, Zabala R et al.,
Value of ultrasound‐guided core biopsy in the
diagnosis of malignant lymphoma. Journal of
Clinical Ultrasound;35(6), 2007, 295-301.